How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers

Journal of Law, Medicine and Ethics 47 (3):369-373 (2019)
  Copy   BIBTEX

Abstract

Although data sharing platforms host diverse data types the features of these platforms are well-suited to facilitating biomarker research. Given the current state of biomarker discovery, an innovative paradigm to accelerate biomarker discovery is to utilize platforms such as Vivli to leverage researchers' abilities to integrate certain classes of biomarkers.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Challenges of web-based personal genomic data sharing.Pascal Borry & Mahsa Shabani - 2015 - Life Sciences, Society and Policy 11 (1):1-13.
The Power of the Crowd in the Sharing Economy.Michal S. Gal - 2019 - The Law and Ethics of Human Rights 13 (1):29-59.
Openness in the social sciences: Sharing data.Joan E. Sieber - 1991 - Ethics and Behavior 1 (2):69 – 86.
New Technology Meets Age-Old Problems.Alison Holt - 2016 - Philosophy and Technology 29 (4):393-395.

Analytics

Added to PP
2019-09-28

Downloads
5 (#1,510,250)

6 months
2 (#1,232,442)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Biomarker Validation: Context and Complexities.Lisa M. McShane - 2019 - Journal of Law, Medicine and Ethics 47 (3):388-392.

Add more citations

References found in this work

No references found.

Add more references